Please use this identifier to cite or link to this item: http://repositorio.cedes.org/handle/123456789/4481
DC FieldValueLanguage
dc.contributor.authorMorgan, Karenen_US
dc.contributor.authorDe Sanjose, Silviaen_US
dc.contributor.authorDi Bona, Vito Len_US
dc.contributor.authorRichter, Karin Len_US
dc.contributor.authorLevitz, Laurenen_US
dc.contributor.authorSmith, Jennifer Sen_US
dc.contributor.authorRamos, Silvinaen_US
dc.contributor.authorKim, Chan Jooen_US
dc.contributor.authorDizon, A Mitchen_US
dc.contributor.authorTopazian, Hillary Men_US
dc.date.accessioned2019-05-03T02:51:48Z-
dc.date.available2019-05-03T02:51:48Z-
dc.date.issued2019-01-09-
dc.identifier.urihttps://www.tandfonline.com/doi/abs/10.1080/21645515.2018.1558688?journalCode=khvi20-
dc.identifier.urihttp://repositorio.cedes.org/handle/123456789/4481-
dc.description.abstractPURPOSE: To examine provider knowledge of HPV vaccination age guidelines in five countries. METHODS: A total of 151 providers of adolescent vaccinations in Argentina, Malaysia, South Africa, South Korea, and Spain were interviewed between October 2013 and April 2014. Univariate analyses compared providers' understanding of recommended age groups for HPV vaccination to that of each country's national guidelines. RESULTS: In three of five countries surveyed, most providers (97% South Africa, 95% Argentina, 87% Malaysia) included all nationally recommended ages in their target age group. However, a relatively large proportion of vaccinators in some countries (83% Malaysia, 55% Argentina) believed that HPV vaccination was recommended for women above age 26, far exceeding national guidelines, and beyond the maximum recommended age in the United States. National median minimum and maximum age recommendations cited by the respondents for HPV vaccination were 11 and 29 years in Argentina (national guideline: 11-14), 13 and 48 years in Malaysia (guideline 13-14), 8 and 14 years in South Africa (guideline 9-14), 10 and 20 years in South Korea (guideline 11-14), and 11 and 12 years in Spain (guideline 11-14). In all countries, a higher percentage of vaccinators included all nationally recommended ages for vaccination, as compared to providers who did not administer HPV vaccination. CONCLUSIONS: Overall, a substantial proportion of providers incorrectly reported their country's age guidelines for HPV vaccination, particularly the upper age limit. As provider recommendation is among the strongest predictors of successful vaccination uptake among adolescents, improved education and clarification of national guidelines for providers administering HPV vaccination is essential to optimize prevention of infection and associated disease.en_US
dc.description.sponsorshipÁrea de Salud, Economía y Sociedades
dc.language.isoenen_US
dc.publisher2164-554Xen_US
dc.subjectADOLESCENTESen_US
dc.subjectVACUNAS CONTRA PAPILLOMAVIRUSen_US
dc.subjectVACUNA CONTRA HPVen_US
dc.subjectPersonal de Saluden_US
dc.titleAdolescent providers' knowledge of human papillomavirus vaccination age guidelines in five countriesen_US
dc.typeArtículoen_US
dc.identifier.doi2164-554X-
dc.identifier.doi1-6-
dc.identifier.doi10.1080/21645515.2018.1558688-
dc.identifier.pmid30625017-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptCEDES. Centro de Estudio de Estado y Sociedad-
crisitem.author.deptÁrea de Salud, Economía y Sociedad-
crisitem.author.parentorgCEDES. Centro de Estudio de Estado y Sociedad-
Appears in Collections:Artículos en publicaciones periódicas
Show simple item record

Page view(s)

73
checked on Mar 2, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.